Zurcher Kantonalbank (Zurich Cantonalbank) Cytokinetics Inc Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $32.8 Billion
- Q3 2024
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Cytokinetics Inc stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 26,376 shares of CYTK stock, worth $1.28 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,376
Previous 26,376
-0.0%
Holding current value
$1.28 Million
Previous $1.39 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding CYTK
# of Institutions
406Shares Held
125MCall Options Held
4.61MPut Options Held
2.46M-
Black Rock Inc. New York, NY14.7MShares$711 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$570 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$470 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$377 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$313 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.56B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...